This chapter discusses a comparison between the effects of psilocybin and Essatalopram on individuals with depression. It delves into the study findings, highlighting the higher efficacy of psilocybin in achieving remission and its ability to disrupt depression-causing circuits in the brain.
Major trials are bringing us a step closer to seeing psychedelic substances used in therapy practice for PTSD, anxiety and depression. On this episode of All in the Mind, we take a look at where the research is currently at.